CLINICAL_TRIALS trial_result · 2014-10-21

Clinical Trial Update: Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer [Phase 2]

A Phase 2 trial evaluating non-cytotoxic suramin as a chemosensitizer for non-small cell lung cancer was terminated, and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Optimum Therapeutics, LLC | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-10-21